This course is suited for the practitioner who is working with or wants to work with women who have breast cancer. The course is focused towards practitioners who seek to develop or further their expertise in the use of nutritional and botanical therapies in combination with conventional cancer treatments and management. The course is designed to give you advanced skills in evaluation and treatment of breast cancer with an emphasis on evidenced based natural and conventional therapies while also maintaining a respect for the value of clinical experience and empirical knowledge. This course will also pay specific attention to issues in co-management: antioxidants with chemotherapy and/or radiation, drug-nutrient-herb interactions, maximizing therapeutic outcomes with complementary treatments, minimizing side effects of conventional treatments, and managing common complications. Our faculty for this course exceeds our highest hopes, and includes nationally and internationally known clinicians, authors and researchers. We are honored and privileged to have the appearance of Ralph Moss, Ph.D., internationally known medical writer/researcher on integrative oncology, specializing in world wide alternative cancer treatments. We are incredibly fortunate to have one of the nation?s leading radiologists in women?s imaging, Amy Thurmond, M.D. Lise Alschuler, N.D., Paul Reilly, N.D., L.Ac. and Michelle Qaqundah, N.D. bring their extraordinary clinical experience and expertise in integrative cancer management from Cancer Treatment Centers of America. Medical oncologist and researcher Kasra Karamlou, M.D. has a unique perspective as a conventionally trained oncologist, but years of experience in integrative breast cancer care. Well-known surgeon Dr. Judith Richmond is unique in her collaborative management with alternative practitioners. Dr. Lillian Nail is a sought after speaker/educator and a first time faculty member for our course. Jonathan Treasure, MA, RH (AHG) brings a depth and breadth of knowledge to the topic of botanical medicine and cancer not easily surpassed. This weekend he will highlight a whole system model for the treatment of stage 4 breast cancer patients.